Disclosing Potential Therapeutic Targets Associated With Osimertinib Resistance in the Non-small Cell Lung Cancer Cell Line H1975
Anticancer Research · 2023
DOI: 10.21873/anticanres.16749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Xuexia Tong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, Ningxia, P.R. China xuexiatong@126.com. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, Ningxia, P.R. China xuexiatong@126.com.
- Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, Ningxia, P.R. China.
- Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, Ningxia, P.R. China lifang@nxmu.edu.cn.
Zitieren
APA
Tong, X., Zhang, R., Sun, R., Yang, W., Sun, J., Chen, J., & Li, F. (2023). Disclosing Potential Therapeutic Targets Associated With Osimertinib Resistance in the Non-small Cell Lung Cancer Cell Line H1975. Anticancer Research. https://doi.org/10.21873/anticanres.16749
Vancouver
Tong X, Zhang R, Sun R, Yang W, Sun J, Chen J, et al. Disclosing Potential Therapeutic Targets Associated With Osimertinib Resistance in the Non-small Cell Lung Cancer Cell Line H1975. Anticancer Research. 2023. doi:10.21873/anticanres.16749
BibTeX
@article{Tong2023,
author = {Tong, Xuexia and Zhang, Rui and Sun, Rong and Yang, Weizhi and Sun, Jinhan and Chen, Juan and Li, Fang},
title = {Disclosing Potential Therapeutic Targets Associated With Osimertinib Resistance in the Non-small Cell Lung Cancer Cell Line H1975},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16749}
}
EUVIMED